WaveMan · Form 4
Valantine Hannah insider trades
> Search tickers & screens ⌘K
LIVE

Valantine Hannah insider trades

Valantine Hannah has filed 38 Form 4s with the SEC that we hold, for BridgeBio Pharma, Inc. (BBIO) (Director), CareDx, Inc. (CDNA) (Director) and Pacific Biosciences Of California, INC. (PACB) (Director). Across all of them we count 7 purchases worth $149.5K and 20 sales worth $7.1M reported on Form 4. In the last 12 months: 0 purchases ($0) and 9 sales ($5.7M). The largest single trade was a sale of 25,484 shares of BridgeBio Pharma, Inc. worth $1.7M, dated 2025-11-12. The first filing on our record is dated 2021-07-02 and the latest 2026-07-17.

BridgeBio Pharma, Inc. (BBIO)

Director · 21 filings · 23 purchases and sales
Trade dateCodeSharesValue as filedFiled
2021-12-28P, purchase reported on Form 41,891$24.9K2024-02-13
2021-12-28P, purchase reported on Form 41,542$19.6K2024-02-13
2021-12-28P, purchase reported on Form 41,891$24.9K2024-02-13
2021-12-28P, purchase reported on Form 41,542$19.6K2025-06-30
2021-12-28P, purchase reported on Form 4796$10.5K2025-06-30
2021-12-29P, purchase reported on Form 41,764$25.1K2022-01-03
2021-12-29P, purchase reported on Form 41,752$24.9K2025-06-30
2023-11-15S, sale reported on Form 42,915$87.5K2023-11-17
2023-12-15S, sale reported on Form 42,915$105.3K2023-12-19
2024-01-16S, sale reported on Form 42,915$110.7K2024-01-18
2024-02-15S, sale reported on Form 42,915$110.0K2024-02-20
2025-03-06S, sale reported on Form 412,875$419.5K2025-03-10
2025-06-10S, sale reported on Form 44,292$171.7K2025-06-11
2025-06-26S, sale reported on Form 41,891$83.3K2025-06-30
2025-06-26S, sale reported on Form 4398$17.6K2025-06-30
2025-06-26S, sale reported on Form 41,542$67.9K2025-06-30
2025-06-26S, sale reported on Form 4876$38.6K2025-06-30
2025-11-12S, sale reported on Form 425,484$1.7M2025-11-14
2026-02-27S, sale reported on Form 410,900$739.5K2026-03-03
2026-02-27S, sale reported on Form 414,584$978.3K2026-03-03
2026-03-10S, sale reported on Form 48,671$624.3K2026-03-12
2026-06-22S, sale reported on Form 42,808$190.9K2026-06-24
2026-06-23S, sale reported on Form 42,196$150.6K2026-06-24

CareDx, Inc. (CDNA)

Director · 13 filings · 4 purchases and sales
Trade dateCodeSharesValue as filedFiled
2025-06-18S, sale reported on Form 410,570$202.5K2025-06-23
2026-06-15S, sale reported on Form 412,103$279.7K2026-06-16
2026-07-16S, sale reported on Form 428,679$1.0M2026-07-17
2026-07-16S, sale reported on Form 4100$3.7K2026-07-17

Pacific Biosciences Of California, INC. (PACB)

Director · 5 filings · 0 purchases and sales

No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.

Source

Counted from the Form 4 filings this reporting owner (SEC CIK 1855608) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.

Source: U.S. Securities and Exchange Commission (EDGAR) and other official government data · Updated 2026-10-12 · For informational purposes only, not investment advice.
Privacy · Terms